Management of severe asthma: Summary of the european respiratory society/American thoracic society task force report

Abstract

Educational aims This article is mainly intended for trainees and specialists who are interested in the management of severe asthma. It aims to inform readers about the updated ERS/ATS recommendations for management of severe asthma, specifically on the topics of biologics, macrolides and long-acting muscarinic antagonists. It also provides guidance on utilisation of available biomarkers in selecting advanced therapies in severe asthma.